Nativis, Inc. announced today that Chris Rivera, president of the Washington Biotechnology and Biomedical Association (WBBA), founder and former CEO of Hyperion Therapeutics, was appointed to the company’s board of directors.
“Chris has extraordinary biotechnology industry and business expertise, and we are delighted that he is joining Nativis’s board of directors,” said John Butters, Nativis’s chairman.
“Chris has extraordinary biotechnology industry and business expertise, and we are delighted that he is joining Nativis’s board of directors,” said John Butters, Nativis’s chairman.
